Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators

Brain Research

Volumn 1076, Issue 1, 2006, Pages 25-41

  Kessler, Markus ^a   Arai, Amy C ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BDP 20; Binding; CX546; CX614; Homomeric receptor

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; [3 H]FLUOROWILLARDIINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BENZAMIDE; CYCLOTHIAZIDE; EVANS BLUE; SPERMINE; SURAMIN; TOPIRAMATE; UNCLASSIFIED DRUG; WILLARDIINE; 5 FLUOROWILLARDIINE; 5-FLUOROWILLARDIINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALANINE; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; AMPA RECEPTOR; BENZODIAZEPINE DERIVATIVE; CYCLOPEPTIDE; CYCLOTHIALIDINE; DRUG DERIVATIVE; PYRIMIDINE DERIVATIVE; TRITIUM;

ARTICLE; BRAIN MEMBRANE; DRUG BINDING; DRUG EFFECT; DRUG STRUCTURE; PRIORITY JOURNAL; ANIMAL; BINDING COMPETITION; BINDING SITE; BRAIN; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG INTERACTION; MALE; MEMBRANE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ALANINE; ALLOSTERIC SITE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZODIAZEPINES; BINDING, COMPETITIVE; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMBRANES; PEPTIDES, CYCLIC; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; TRITIUM;

EID: 33644852958     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.09.024     Document Type: Article

References (82)

1. P.H. Andersen, C.K. Tygesen, J.S. Rasmussen, L. Soegaard-Nielsen, A. Hansen, K. Hansen, A. Kiemer, and C.E. Stidsen Stable expression of homomeric AMPA-selective glutamate receptors in BHK cells Eur. J. Pharmacol. 31 1996 95 100
2. A.C. Arai GYKI 52466 has positive modulatory effects on AMPA receptors Brain Res. 892 2001 396 400
3. A. Arai, and G. Lynch The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization Brain Res. 799 1998 230 234
4. A. Arai, M. Kessler, P. Xiao, J. Ambros-Ingerson, G. Rogers, and G. Lynch A centrally active drug that modulates AMPA receptor gated currents Brain Res. 638 1994 343 346
5. A. Arai, J. Silberg, M. Kessler, and G. Lynch Effect of thiocyanate on AMPA receptor mediated responses in excised patches and hippocampal slices Neuroscience 66 1995 815 827
6. A. Arai, M. Kessler, A. Quan, E. Yigiter, J. Ambros-Ingerson, G. Rogers, and G. Lynch Effects of a centrally active drug on AMPA receptor kinetics Neuroscience 75 1996 573 585
7. A. Arai, M. Kessler, G. Rogers, and G. Lynch Effects of a memory enhancing drug on AMPA receptor currents and synaptic transmission in hippocampus J. Pharmacol. Exp. Ther. 278 1996 627 638
8. A.C. Arai, M. Kessler, G. Rogers, and G. Lynch Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466 Mol. Pharmacol. 58 2000 802 813
9. A.C. Arai, M. Kessler, Y.-F. Xia, G. Rogers, and G. Lynch Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action J. Pharmacol. Exp. Ther. 303 2002 1075 1085
10. A.C. Arai, M. Kessler, Y.-F. Xia, D. Phillips, R. Granger, R. Chamberlin, and G. Lynch Effects of newly developed benzothiadiazide compounds on AMPA receptor mediated currents and synaptic responses Mol. Pharmacol. 62 2002 566 577
11. A.C. Arai, Y.-F. Xia, and E. Suzuki Modulation of AMPA receptor kinetics differentially influences formation of synaptic plasticity in the hippocampus Neuroscience 123 2004 1011 1024
12. B.A. Bahr, J. Bendiske, Q.B. Brown, S. Munirathinam, E. Caba, M. Rudin, S. Urwyler, A. Sauter, and G. Rogers Survival signaling and selective neuroprotection through glutamatergic transmission Exp. Neurol. 174 2002 37 47
13. P. Baumbarger, M. Muhlhauser, C.R. Yang, and E.S. Nisenbaum LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons Neuropharmacology 40 2001 992 1002
14. P.J. Baumbarger, M. Muhlhauser, J. Zhai, C.R. Yang, and E.S. Nisenbaum Positive modulation of AMPA receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator J. Pharmacol. Exp. Ther. 298 2001 86 102
15. M. Bertolino, M. Baraldi, C. Parenti, D. Braghiroli, M. DiBella, S. Vicini, and E. Costa Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus Recept. Channels 1 1993 267 278
16. D. Bowie, and M.L. Mayer Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block Neuron 15 1995 453 462
17. D. Bowie, and T.G. Smart Thiocyanate ions selectively antagonize AMPA-evoked responses in Xenopus laevis oocytes microinjected with rat brain mRNA Br. J. Pharmacol. 109 1993 779 787
18. D. Bowie, G.D. Lange, and M.L. Mayer Activity-dependent modulation of glutamate receptors by polyamines J. Neurosci. 18 1998 8175 8185
19. M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
20. I. Bresink, B. Ebert, C.G. Parsons, and E. Mutschler Zinc changes AMPA receptor properties: results of binding studies and patch clamp recordings Neuropharmacology 35 1996 503 509
21. P. Desos, B. Serkiz, P. Morain, J. Lepagnol, and A.A. Cordi Enantioselective synthesis of a pyrrolo-benzothiadiazine derivative S18986, a new AMPA receptor positive modulator Bioorganic Med. Chem. Letters 6 1996 3003 3008
22. E. Dicou, C.M. Rangon, F. Guimiot, M. Spedding, and P. Gressens Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain Brain Res. 970 2003 221 225
23. S.D. Donevan, and M.A. Rogawski Allosteric regulation of AMPA receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines Neuroscience 87 1998 615 629
24. J.C. Dreixler, and J.P. Leonard Effects of external calcium on zinc modulation of AMPA receptors Brain Res. 752 1997 170 174
25. F. Fallarino, A. Genazzani, S. Silla, M.R. L'Episcopo, O. Camici, L. Corazzi, F. Nicoletti, and M.C. Fioretti [3H]Aniracetam binds to specific recognition sites in brain membranes J. Neurochem. 65 1995 912 918
26. D.S. Gryder, and M.A. Rogawski Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons J. Neurosci. 23 2003 7069 7074
27. R.J. Hall, M. Kessler, and G. Lynch Evidence that high and low affinity AMPA binding sites reflect membrane-dependent states of a single receptor J. Neurochem. 59 1992 1997 2004
28. R.A. Hall, M. Kessler, A. Quan, J. Ambros-Ingerson, and G. Lynch Cyclothiazide decreases [3H]AMPA binding to rat brain membranes: evidence that AMPA receptor desensitization increases agonist affinity Brain Res. 628 1993 345 348
29. R.A. Hall, M. Massicotte, M. Kessler, M. Baudry, and G. Lynch Thiocyanate equally increases affinity for two AMPA receptor states Mol. Pharmacol. 43 1993 459 464
30. R.E. Hampson, G. Rogers, G. Lynch, and S.A. Deadwyler Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed nonmatch to sample performance J. Neurosci. 18 1998 2740 2747
31. L.M. Hawkins, K.M. Beaver, D.E. Jane, P.M. Taylor, D.C. Sunter, and P.J. Roberts Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain Br. J. Pharmacol. 116 1995 2033 2039
32. M. Hennegriff, A. Arai, M. Kessler, P. Vanderklish, M.S. Mutneja, G. Rogers, R.L. Neve, and G. Lynch Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators J. Neurochem. 68 1997 2424 2434
33. T. Honore, and J. Drejer Chaotropic ions affect the conformation of quisqualate receptors in rat cortical membranes J. Neurochem. 51 1988 457 461
34. 3H]CNQX binds with equal affinity to two agonist states of quisqualate receptors Biochem. Pharmacol. 38 1989 3207 3212
35. I. Ito, S. Tanabe, A. Kohda, and H. Sugiyama Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam J. Physiol. (London) 424 1990 533 543
36. D.E. Jane, K. Hoo, R. Kamboj, M. Deverill, D. Bleakman, and A. Mandelzys Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes J. Med. Chem. 40 1997 3645 3650
37. T.H. Johansen, A. Chaudhary, and T.A. Verdoorn Interactions among GYKI-52466, cyclothiazide and aniracetam at recombinant AMPA and kainate receptors Mol. Pharmacol. 48 1995 946 955
38. S.A. Johnson, N.T. Luu, T.A. Herbst, R. Knapp, D. Lutz, A. Arai, G.A. Rogers, and G. Lynch Synergistic interactions between ampakines and antipsychotic drugs J. Pharmacol. Exp. Ther. 289 1999 392 397
39. B.U. Keller, M. Blaschke, R. Rivosecchi, M. Hollmann, S.F. Heinemann, and A. Konnerth Identification of a subunit-specific antagonist of AMPA/kainate receptor channels Proc. Natl. Acad. Sci. U. S. A. 90 1993 605 609
40. M. Kessler, A. Arai, A. Quan, and G. Lynch Effect of cyclothiazide on binding properties of AMPA type glutamate receptors: Lack of competition between cyclothiazide and GYKI 52466 Mol. Pharmacol. 49 1996 123 131
41. M. Kessler, G. Rogers, and A.C. Arai The norbornyl moiety of cyclothiazide determines the preference for flip-flop variants of AMPA receptor subunits Neurosci. Lett. 287 2000 161 165
42. R.J. Knapp, R. Goldenberg, C. Shuck, A. Cecil, J. Watkins, C. Miller, G. Crites, and E. Malatynska Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model Eur. J. Pharmacol. 440 2002 27 35
43. M. Koike, M. Iino, and S. Ozawa Blocking effect of 1-naphthyl acetyl spermine on Ca(2+)-permeable AMPA receptors in cultured rat hippocampal neurons Neurosci. Res. 29 1997 27 36
44. I. Kovacs, A. Simon, E. Szarics, P. Barabas, L. Laszlo, L. Nyikos, and J. Kardos Cyclothiazide binding to functionally active AMPA receptors reveals genuine allosteric interaction with agonist binding sites Neurochem. Int. 44 2004 271 280
45. J. Larson, T. Lieu, V. Petchpradub, B. LeDuc, H. Ngo, G. Rogers, and G. Lynch Facilitation of olfactory learning by a modulator of AMPA receptors J. Neurosci. 15 1995 8023 8030
46. J.C. Lauterborn, G.S. Truong, M. Baudry, X. Bi, G. Lynch, and C.M. Gall Chronic elevation of brain-derived neurotrophic factor by ampakines J. Pharmacol. Exp. Ther. 307 2003 297 305
47. J.J. Lawrence, S. Brenowitz, and L.O. Trussell The mechanism of action of aniracetam at synaptic AMPA receptors: indirect and direct effects on desensitization Mol. Pharmacol. 64 2003 269 278
48. S. Lei, and J.F. MacDonald Gadolinium reduces AMPA receptor desensitization and deactivation in hippocampal neurons J. Neurophysiol. 86 2001 173 182
49. B. Lin, F.A. Brucher, L.L. Colgin, A.C. Arai, and G. Lynch Interactions between recording technique and AMPA receptor modulators Brain Res. 955 2002 164 173
50. A.M. Linden, H. Yu, H. Zarrinmayeh, W.J. Wheeler, and P. Skolnick Binding of an AMPA receptor potentiator ([3H]LY395153) to native and recombinant AMPA receptors Neuropharmacology 40 2001 1010 1018
51. G. Lynch, R. Granger, J. Ambros-Ingerson, C.M. Davis, R. Schehr, and M. Kessler Evidence that a positive modulator of AMPA-type glutamate receptors affects delayed recall in aged humans Exp. Neurol. 145 1997 89 92
52. P. Miu, K.R. Jarvie, V. Radhakrishnan, M.R. Gates, A. Ogden, P.L. Ornstein, H. Zarrinmayeh, K. Ho, D. Peters, J. Grabell, A. Gupta, D.M. Zimmerman, and D. Bleakman Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro Neuropharmacology 40 2001 976 983
53. 3H]AMPA to non-chaotrope, non-detergent treated rat synaptic membranes: characteristics and lack of effect of barbiturates Neurochem. Int. 18 1991 75 84
54. 3H]amino- 3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and filtration assay Neurochem. Res. 12 1987 775 782
55. T.K. Murray, K. Whalley, C.S. Robinson, M.A. Ward, C.A. Hicks, D. Lodge, J.L. Vandergriff, P. Baumbarger, E. Siuda, M. Gates, A.M. Ogden, P. Skolnick, D.M. Zimmerman, E.S. Nisenbaum, D. Bleakman, and M.J. O'Neill LY503430, a novel AMPA receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease J. Pharmacol. Exp. Ther. 306 2003 752 762
56. N. Nagarajan, C. Quast, A.R. Boxall, M. Shahid, and C. Rosenmund Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546 Neuropharmacology 41 2001 650 663
57. S. Nishimura, M. Iizuka, M. Wakamori, I. Akiba, K. Imoto, and E.L. Barsoumian Stable expression of human homomeric and heteromeric AMPA receptor subunits in HEK293 cells Recept. Channels 7 2000 139 150
58. 3H]AMPA binding to glutamate receptor subpopulations in rat brain Brain Res. 402 1994 243 254
59. K.M. Partin, and M.L. Mayer Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655 Mol. Pharmacol. 49 1996 142 148
60. K.M. Partin, D.K. Patneau, and M.L. Mayer Cyclothiazide differentially modulates desensitization of AMPA receptor splice variants Mol. Pharmacol. 46 1994 129 138
61. K.M. Partin, M.W. Fleck, and M.L. Mayer AMPA receptor flip/flop mutants affecting deactivation, desensitization and modulation by cyclothiazide, aniracetam and thiocyanate J. Neurosci. 16 1996 6634 6647
62. A.V. Paternain, M. Morales, and J. Lerma Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons Neuron 14 1995 185 189
63. J.C. Pelletier, D.P. Hesson, K.A. Jones, and A.M. Costa Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor J. Med. Chem. 39 1996 343 346
64. B. Pirotte, T. Podona, O. Diouf, P. de Tullio, P. Lebrun, L. Dupont, F. Somers, J. Delarge, P. Morain, P. Lestage, J. Lepagnol, and M. Spedding 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of AMPA receptors: design, synthesis, pharmacology, and structure-activity relationships J. Med. Chem. 41 1998 2946 2959
65. C.J. Price, and L.A. Raymond Evans blue antagonizes both AMPA and kainate receptors and modulates receptor desensitization Mol. Pharmacol. 50 1996 1665 1671
66. G. Rammes, D. Swandulla, G.L. Collingridge, S. Hartmann, and C.G. Parsons Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices Br. J. Pharmacol. 117 1996 1209 1221
67. M. Sekiguchi, M.W. Fleck, M.L. Mayer, J. Takeo, Y. Chiba, S. Yamashita, and K. Wada A novel allosteric potentiator of AMPA receptors: 42-(phenylsulfonylamino)ethylthio-2,6-difluoro-phenoxyacetamide J. Neurosci. 17 1997 5760 5771
68. B. Sommer, K. Keinanen, T.A. Verdoorn, W. Wisden, N. Burnashev, A. Herb, M. Kohler, T. Takagi, B. Sakmann, and P.H. Seeburg Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS Science 249 1990 1580 1585
69. S. Standley, N. Irvin, and M. Baudry Differential subcellular localization of two populations of glutamate/AMPA receptors in the rat telencephalon Neurochem. Int. 25 1994 287 293
70. S. Standley, G. Tocco, N. Wagle, and M. Baudry High- and low-affinity [3H]AMPA binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits J. Neurochem. 70 1998 2434 2445
71. U. Staubli, G. Rogers, and G. Lynch Facilitation of glutamate receptors enhances memory Proc. Natl. Acad. Sci. U. S. A. 91 1994 777 781
72. K. Stromgaard, and I. Mellor AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins Med. Res. Rev. 24 2004 589 620
73. Y. Sun, R. Olson, M. Horning, N. Armstrong, M. Mayer, and E. Gouaux Mechanism of glutamate receptor desensitization Nature 417 2002 245 253
74. E. Suzuki, M. Kessler, K. Montgomery, and A.C. Arai Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5′-phosphate-6- (2′-naphthylazo-6′-nitro-4′,8′-disulfonate) (PPNDS) on AMPA receptors Mol. Pharmacol. 66 2004 1738 1747
75. I. Tarnawa, P. Molnar, L. Gaal, and F. Andrasi Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo Acta Physiol. Hung. 79 1992 163 169
76. M.S. Washburn, and R. Dingledine Block of AMPA receptors by polyamines and polyamine toxins J. Pharmacol. Exp. Ther. 278 1996 669 678
77. E. Weigand, and B.U. Keller Functional diversity of synaptic AMPA/KA receptors from rat as revealed by subtype-specific antagonists Eur. J. Neurosci. 10 1998 64 70
78. T. Weiser, A. Herrmann, and M. Wienrich Interactions of the dye Evans Blue and GYKI 52466, a 2,3-benzodiazepine, with AMPA receptors in cultured rat cortical neurons: electrophysiological evidence for at least two different binding sites for non-competitive antagonists Neurosci. Lett. 216 1996 29 32
79. Y.-F. Xia, M. Kessler, and A.C. Arai Positive AMPA receptor modulators have different impact on synaptic transmission in the thalamus and hippocampus J. Pharmacol. Exp. Ther. 313 2005 277 285
80. P. Xiao, U. Staubli, M. Kessler, and G. Lynch Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus Hippocampus 1 1991 373 380
81. K.A. Yamada, and S.M. Rothman Diazoxide blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurons J. Physiol. 458 1992 409 423
82. K.A. Yamada, and C.-M. Tang Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents J. Neurosci. 13 1993 3904 3915